Stay updated on EG-1962 vs Oral Nimodipine in Subarachnoid Hemorrhage Clinical Trial
Sign up to get notified when there's something new on the EG-1962 vs Oral Nimodipine in Subarachnoid Hemorrhage Clinical Trial page.

Latest updates to the EG-1962 vs Oral Nimodipine in Subarachnoid Hemorrhage Clinical Trial page
- CheckyesterdayChange DetectedAdded navigation/help sections and standardized the Intervention/Treatment heading; updated the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check8 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a page revision update.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.5.4 has been added, replacing the previous v3.5.3. This represents a minor platform version update and does not modify the study details or other user-visible content.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded leadership and collaborators details and PubMed publications for the NEWTON2 study. This expands the Collaborators and Publications sections to reflect governance and related literature.SummaryDifference74%

- Check51 days agoChange DetectedThe page has removed multiple study-specific details, including condition/MeSH keywords, study record history and dates, related publications, and sections describing the trial’s design and arms (interventions, masking, outcomes, eligibility, and study timeline). This reduces the amount of concrete information available for understanding the study and evaluating participation.SummaryDifference15%

- Check58 days agoChange DetectedThe page now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to EG-1962 vs Oral Nimodipine in Subarachnoid Hemorrhage Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EG-1962 vs Oral Nimodipine in Subarachnoid Hemorrhage Clinical Trial page.